Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6788)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 15, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Grapsa D, Saif MW, Syrigos K. Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go? World J Gastrointest Oncol 2015; 7(10): 172-177 [PMID: 26483872 DOI: 10.4251/wjgo.v7.i10.172] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i10/172.htm |
| Number | Citing Articles |
| 1 |
Dimitra Grapsa, Konstantinos Syrigos, Muhammad Wasif Saif. Nanoliposomal irinotecan for treating pancreatic cancer. Expert Opinion on Orphan Drugs 2016; 4(5): 541 doi: 10.1517/21678707.2016.1169171
|
| 2 |
Talia Golan, Chani Stossel, Michael Schvimer, Dikla Atias, Sharon Halperin, Ella Buzhor, Maria Raitses-Gurevich, Keren Cohen, Sara Pri-Chen, Julie Wilson, Robert E. Denroche, Ilinca Lungu, John M.S. Bartlett, Faridah Mbabaali, Yosef Yarden, Nishanth Belugali Nataraj, Steven Gallinger, Raanan Berger. Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease. Oncotarget 2017; 8(25): 40778 doi: 10.18632/oncotarget.17253
|
| 3 |
Gaopan Dong, Long Chen, Jing Zhang, Tingting Liu, Lupei Du, Chunquan Sheng, Minyong Li. Discovery of Turn-On Fluorescent Probes for Detecting PDEδ Protein in Living Cells and Tumor Slices. Analytical Chemistry 2020; 92(14): 9516 doi: 10.1021/acs.analchem.0c00335
|
| 4 |
Chuan Liu, Xiaowei Fu, Zhiwei Zhong, Jing Zhang, Haiyan Mou, Qiong Wu, Tianle Sheng, Bo Huang, Yeqing Zou. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. Digestive Diseases and Sciences 2017; 62(9): 2376 doi: 10.1007/s10620-017-4641-8
|
| 5 |
Nauman S. Siddiqui, Amandeep Godara, Margaret M. Byrne, Muhammad Wasif Saif. Capecitabine for the treatment of pancreatic cancer. Expert Opinion on Pharmacotherapy 2019; 20(4): 399 doi: 10.1080/14656566.2018.1560422
|
| 6 |
Jianfei Huang, Haijun Mei, Zhiyuan Tang, Jieying Li, Xiaojing Zhang, Yixiang Lu, Fang Huang, Qin Jin, Zhiwei Wang. Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation. Journal of Controlled Release 2017; 245: 1 doi: 10.1016/j.jconrel.2016.11.024
|